You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-PD-L1 monoclonal antibody

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (recombinant anti-PD-L1 mAb injection combined with carboplatin and

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
May 9, 2022

Solid Tumors, Adult Trial in Kaunas (NECVAX-NEO1)

Recruiting
  • Solid Tumors, Adult
  • NECVAX-NEO1
  • Kaunas, Lithuania
    Elona Juozaityte
May 16, 2022

Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

Not yet recruiting
  • Colon Neoplasm
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Jun 25, 2023

Local Progression or Metastatic Melanoma With Failed First-line Treatment Trial in Beijing (Pexa-Vec combined with ZKAB001,

Recruiting
  • Local Progression or Metastatic Melanoma With Failed First-line Treatment
  • Pexa-Vec combined with ZKAB001
  • ZKAB001 monotherapy
  • Beijing, China
    Beijing Cancer Hospital
Mar 30, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Sacramento (Anti-PD-L1 Monoclonal Antibody MPDL3280A,

Terminated
  • Recurrent Non-Small Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer
  • Anti-PD-L1 Monoclonal Antibody MPDL3280A
  • Stereotactic Body Radiation Therapy
  • Sacramento, California
    University of California Davis
Aug 2, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Solid Tumor Trial in Richmond (Stereotactic radiotherapy, Biological: humanized anti-PD-1 mAb, Biological: humanized anti-PD-L1

Completed
Has Results
  • Solid Tumor
  • Stereotactic radiotherapy
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 20, 2021

Advanced Cancer Trial in Beijing, Shanghai (CS1001)

Completed
  • Advanced Cancer
  • Beijing, Beijing, China
  • +1 more
May 25, 2022

Solid Tumor Trial (IN10018, Nab-paclitaxel, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Aug 1, 2023

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Advanced or Metastatic Solid Tumors Trial in Kawasaki, Tokyo (KN035)

Completed
  • Advanced or Metastatic Solid Tumors
  • Kawasaki, Japan
  • +1 more
Feb 7, 2022

Advanced Solid Tumors Trial in San Antonio (CS1001)

Completed
  • Advanced Solid Tumors
  • San Antonio, Texas
    NEXT Oncology
Feb 15, 2022

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023

Advanced Solid Tumors Trial in Australia, New Zealand, Spain (BGB-A333, BGB-A317)

Terminated
Has Results
  • Advanced Solid Tumors
  • Clayton, Victoria, Australia
  • +7 more
Oct 12, 2021

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE
  • +8 more
  • Quanzhou, Fujian, China
  • +3 more
Jan 29, 2023

Solid Tumors Trial in Lafayette, San Antonio (KN035)

Completed
  • Solid Tumors
  • Lafayette, Indiana
  • +1 more
May 31, 2021

Advanced Solid Tumor, NSCLC, Small Cell Lung Cancer Trial (IMM2520)

Not yet recruiting
  • Advanced Solid Tumor
  • +5 more
  • (no location specified)
Mar 20, 2023

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Advanced Malignant Tumor Trial in Shanghai (Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant

Recruiting
  • Advanced Malignant Tumor
  • Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)
  • Shanghai, Shanghai, China
    Dragonboat Biopharmaceutical,Co.,Ltd
Feb 3, 2021

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)

Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
Mar 16, 2022

Tumor, Subjects Trial in China, United States (HB0025)

Recruiting
  • Tumor, Subjects
  • San Antonio, Texas
  • +5 more
May 31, 2022

Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Metastatic Non-Small Lung Cell Cancer
  • +4 more
  • Atlanta, Georgia
    Winship Cancer Institute of Emory University
Oct 19, 2022

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023